A014 Transcriptomic analysis of Huntington disease cellular models with different numbers of the CAG repeats and effects of genistein treatments

<h3>Background</h3> Although the primary cause of monogenic diseases are mutations in single genes, recent studies demonstrated that secondary changes in expression of other genes can significantly influence the pathophysiology and cause previously unattended challenges in developing therapeutic approaches.<sup>1</sup> Therefore, monogenic disease might be considered as not simple, but complex disorders where dysregulated expression of many genes may contribute to unexpected changes in the regulatory network. Such a complex picture must be considered when attempting to develop effective treatment. <h3>Aims</h3> To determine changes in the global pattern of gene expression in cellular models of Huntington disease (HD), and to test whether treatment with genistein (an autophagy stimulator which was recently demonstrated to decrease storage of mutant huntingtin and correct behaviour of the R6/1 mouse model of the disease<sup>2</sup>) can normalize the levels of expression of selected genes. <h3>Methods/Techniques</h3> HEK (human embryonic kidney)-derived cell lines with either normal of increased (41, 53, 84) number of the CAG repeats in the HTT gene were used, the latter considered as HD models. The cells were either untreated or treated with genistein at the 50 micromolar concentration. Total RNA was isolated, and transcriptomic analyses were performed using the RNAseq method. <h3>Results/Outcome</h3> We found that there are hundreds of dysregulated genes in HD model cells relative to healthy controls. Expression of some genes was over 10-times up- or down-regulated in HD cells in comparison to controls. Functions of genes involved in some cellular processes were especially heavily affected, with autophagy being a well-pronounced example. Importantly, treatment with genistein could correct expression of some of these genes to the levels observed in controls while improving expression of others. <h3>Conclusions</h3> There are many genes which expression is significantly changed in HD cells relative to controls, with more pronounced dysregulation in cells with higher number of CAG repeats. Treatment with genistein can normalize expression of some genes and improve that of others. <h3>References</h3> Wisniewska K, <i>et al. Curr Issues Mol Biol</i> 2024;<b>46</b>:2678-2700. Pierzynowska K, <i>et al. Autophagy</i> 2024;<b>20</b>:1159-1182.

Authors

Institutions

Publication Details

Published
2024-09-01
DOI
https://doi.org/10.1136/jnnp-2024-ehdn.14
Citations
1
Primary Topic
Genetic Neurodegenerative Diseases
Type
article
Field-Weighted Citation Impact
0.27
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A014 Transcriptomic analysis of Huntington disease cellular models with different numbers of the CAG repeats and effects of genistein treatments

Aneta Szulc, Lidia Gaffke, Karolina Pierzynowska, Magdalena Żabińska et al.
1 citations
Genetic Neurodegenerative Diseases
0.27
article

A014 Transcriptomic analysis of Huntington disease cellular models with different numbers of the CAG repeats and effects of genistein treatments

Aneta Szulc, Lidia Gaffke, Karolina Pierzynowska, Magdalena Żabińska, Estera Rintz, Grzegorz Węgrzyn, Karolina Wiśniewska, Zuzanna Cyske
article en
1 citations

Abstract

<h3>Background</h3> Although the primary cause of monogenic diseases are mutations in single genes, recent studies demonstrated that secondary changes in expression of other genes can significantly influence the pathophysiology and cause previously unattended challenges in developing therapeutic approaches.<sup>1</sup> Therefore, monogenic disease might be considered as not simple, but complex disorders where dysregulated expression of many genes may contribute to unexpected changes in the regulatory network. Such a complex picture must be considered when attempting to develop effective treatment. <h3>Aims</h3> To determine changes in the global pattern of gene expression in cellular models of Huntington disease (HD), and to test whether treatment with genistein (an autophagy stimulator which was recently demonstrated to decrease storage of mutant huntingtin and correct behaviour of the R6/1 mouse model of the disease<sup>2</sup>) can normalize the levels of expression of selected genes. <h3>Methods/Techniques</h3> HEK (human embryonic kidney)-derived cell lines with either normal of increased (41, 53, 84) number of the CAG repeats in the HTT gene were used, the latter considered as HD models. The cells were either untreated or treated with genistein at the 50 micromolar concentration. Total RNA was isolated, and transcriptomic analyses were performed using the RNAseq method. <h3>Results/Outcome</h3> We found that there are hundreds of dysregulated genes in HD model cells relative to healthy controls. Expression of some genes was over 10-times up- or down-regulated in HD cells in comparison to controls. Functions of genes involved in some cellular processes were especially heavily affected, with autophagy being a well-pronounced example. Importantly, treatment with genistein could correct expression of some of these genes to the levels observed in controls while improving expression of others. <h3>Conclusions</h3> There are many genes which expression is significantly changed in HD cells relative to controls, with more pronounced dysregulation in cells with higher number of CAG repeats. Treatment with genistein can normalize expression of some genes and improve that of others. <h3>References</h3> Wisniewska K, <i>et al. Curr Issues Mol Biol</i> 2024;<b>46</b>:2678-2700. Pierzynowska K, <i>et al. Autophagy</i> 2024;<b>20</b>:1159-1182.

University of Gdańsk (PL)
Good health and well-being
Openalex Percentile: Top 45%
Genetic Neurodegenerative Diseases
0.27
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.